"Myelopoiesis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Formation of MYELOID CELLS from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW via MYELOID STEM CELLS. Myelopoiesis generally refers to the production of leukocytes in blood, such as MONOCYTES and GRANULOCYTES. This process also produces precursor cells for MACROPHAGE and DENDRITIC CELLS found in the lymphoid tissue.
Descriptor ID |
D038042
|
MeSH Number(s) |
G04.152.825.597.750 G09.188.343.597.750
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myelopoiesis".
Below are MeSH descriptors whose meaning is more specific than "Myelopoiesis".
This graph shows the total number of publications written about "Myelopoiesis" by people in this website by year, and whether "Myelopoiesis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myelopoiesis" by people in Profiles.
-
Fate mapping of hematopoietic stem cells?reveals two pathways of native thrombopoiesis. Nat Commun. 2022 08 03; 13(1):4504.
-
Aberrant chromatin landscape following loss of the H3.3 chaperone Daxx in haematopoietic precursors leads to Pu.1-mediated neutrophilia and inflammation. Nat Cell Biol. 2021 12; 23(12):1224-1239.
-
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell. 2020 09 17; 182(6):1419-1440.e23.
-
Emerging Principles in Myelopoiesis at Homeostasis and during Infection and Inflammation. Immunity. 2019 02 19; 50(2):288-301.
-
Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. Cell. 2018 01 11; 172(1-2):147-161.e12.
-
Lenalidomide consolidation treatment in patients with multiple myeloma suppresses myelopoieses but spares erythropoiesis. Int J Cancer. 2016 Nov 15; 139(10):2343-52.